Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.38 | -18.94 |
PEG Ratio (TTM) | -0.34 | -5.61 |
P/S Ratio (TTM) | 1.53 | 47.90 |
P/B Ratio (TTM) | -279.48 | 30.89 |
P/FCF Ratio (TTM) | -0.35 | -6.05 |
Price to 5YR AVG Earnings Ratio | -1.10 | -5.69 |
Price to 5YR AVG FCF Ratio | -0.17 | -13.62 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -64.62% | -17.89% |
ROE (TTM) | -322.46% | 28.85% |
Net Profit Margin (TTM) | -565.74% | -540.96% |
ROIC 5YR AVG | -76.54% | -3.04% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11.97% | 4.82% | 23.20% |
Revenue | 13.23% | 114.86% | 212.57% |
Net Income | 1.61% | -3.80% | 12.34% |
Cash Flow | -88.70% | -18.33% | 4.58% |
Health (7%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.51 | 5.75 |
Quick Ratio (TTM) | 0.33 | 5.53 |
D/E Ratio (TTM) | -12.20 | 1.08 |
Interest Coverage (TTM) | -19.69 | -7.40 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 13.03 |
LTL to 5YR AVG FCF | -0.47 | 0.08 |
Shares Outstanding Growth 5YR AVG | 16.67% | 40.65% |